AVXL: Prioritizing core CNS programs and restoring compliance, with a focus on transparency and execution
Regained Nasdaq compliance and addressed internal control weaknesses, with a renewed focus on transparency and disciplined execution. Prioritizing blarcamesine development for Alzheimer's, Rett syndrome, and Fragile X syndrome, while pausing other programs to concentrate resources.Based on Anavex L…